The effect of intraoperative dexmedetomidine on postoperative catheter-related bladder discomfort in patients undergoing transurethral bladder tumour resection: A double-blind randomised study

European Journal of Anaesthesiology

Volumn 32, Issue 9, 2015, Pages 596-601

  Kim, Hyun Chang ^a   Lee, Yong Hun ^a   Jeon, Young Tae ^b   Hwang, Jung Won ^b   Lim, Young Jin ^a   Park, Jung Eun ^a   Park, Hee Pyoung ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; TRAMADOL; ANALGESIC AGENT;

ADULT; AGED; ARTICLE; BLADDER DISCOMFORT; BLADDER TUMOR; CATHETER COMPLICATION; CATHETER RELATED BLADDER DISCOMFORT; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INCIDENCE; INDWELLING URINARY CATHETER; INTRAOPERATIVE PERIOD; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; RANDOMIZED CONTROLLED TRIAL; TRANSURETHRAL RESECTION; XEROSTOMIA; ADVERSE EFFECTS; BLADDER; DRUG EFFECTS; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PATHOLOGY; PEROPERATIVE CARE; PROCEDURES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; URINARY CATHETER;

AGED; ANALGESICS, NON-NARCOTIC; DEXMEDETOMIDINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER NEOPLASMS; URINARY CATHETERS;

EID: 84942580784     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0000000000000196     Document Type: Article

References (30)

1. Agarwal A, Raza M, Singhal V, et al. The efficacy of tolterodine for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study. Anesth Analg 2005; 101:1065-1067.
2. Tauzin-Fin P, Sesay M, Svartz L, et al. Sublingual oxybutynin reduces postoperative pain related to indwelling bladder catheter after radical retropubic prostatectomy. Br J Anaesth 2007; 99:572-575.
3. Guenther U, Radtke FM. Delirium in the postanaesthesia period. Curr Opin Anaesthesiol 2011; 24:670-675.
4. Lepouse C, Lautner CA, Liu L, et al. Emergence delirium in adults in the postanaesthesia care unit. Br J Anaesth 2006; 96:747-753.
5. Agarwal A, Gupta D, Kumar M, et al. Ketamine for treatment of catheter related bladder discomfort: a prospective, randomized, placebo controlled and double blind study. Br J Anaesth 2006; 96:587-589.
6. Agarwal A, Yadav G, Gupta D, et al. Evaluation of intra-operative tramadol for prevention of catheter-related bladder discomfort: a prospective, randomized, double-blind study. Br J Anaesth 2008; 101:506-510.
7. Ryu JH, Hwang JW, Lee JW, et al. Efficacy of butylscopolamine for the treatment of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study. Br J Anaesth 2013; 111:932-937.
8. Farag E, Argalious M, Abd-Elsayed A, et al. The use of dexmedetomidine in anesthesia and intensive care: a review. Curr Pharm Des 2012; 18:6257-6265.
9. Keniya VM, Ladi S, Naphade R. Dexmedetomidine attenuates sympathoadrenal response to tracheal intubation and reduces perioperative anaesthetic requirement. Indian J Anaesth 2011; 55:352-357.
10. Kunisawa T, Ueno M, Kurosawa A, et al. Dexmedetomidine can stabilize hemodynamics and spare anesthetics before cardiopulmonary bypass. J Anesth 2011; 25:818-822.
11. Lee JH, Kim H, Kim HT, et al. Comparison of dexmedetomidine and remifentanil for attenuation of hemodynamic responses to laryngoscopy and tracheal intubation. Korean J Anesthesiol 2012; 63:124-129.
12. Yildiz M, Tavlan A, Tuncer S, et al. Effect of dexmedetomidine on haemodynamic responses to laryngoscopy and intubation: perioperative haemodynamics and anaesthetic requirements. Drugs R D 2006; 7:43-52.
13. Takizuka A, Minami K, Uezono Y, et al. Dexmedetomidine inhibits muscarinic type 3 receptors expressed in Xenopus oocytes and muscarineinduced intracellular Ca2+ elevation in cultured rat dorsal root ganglia cells. Naunyn Schmiedebergs Arch Pharmacol 2007; 375:293-301.
14. Binhas M, Motamed C, Hawajri N, et al. Predictors of catheter-related bladder discomfort in the postanaesthesia care unit. Ann Fr Anesth Reanim 2011; 30:122-125.
15. Nargund VH, Tanabalan CK, Kabir MN. Management of nonmuscleinvasive (superficial) bladder cancer. Semin Oncol 2012; 39:559-572.
16. Rodriguez Faba O, Gaya JM, Lopez JM, et al. Current management of nonmuscle-invasive bladder cancer. Minerva Med 2013; 104:273-286.
17. Bala I, Bharti N, Chaubey VK, Mandal AK. Efficacy of gabapentin for prevention of postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor. Urology 2012; 79:853-857.
18. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J 1974; 2:656-659.
19. Yu D, Chai W, Sun X, Yao L. Emergence agitation in adults: risk factors in 2, 000 patients. Can J Anaesth 2010; 57:843-848.
20. Appell RA. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis. Urology 1997; 50:90-96.
21. Agarwal A, Dhiraaj S, Pawar S, Kapoor R, Gupta D, Singh PK. An evaluation of the efficacy of gabapentin for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study. Anesth Analg 2007; 105:1454-1457.
22. Agarwal A, Dhiraaj S, Singhal V, Kapoor R, Tandon M. Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study. Br J Anaesth 2006; 96:377-380.
23. Iirola T, Ihmsen H, Laitio R, et al. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients. Br J Anaesth 2012; 108:460-468.
24. Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother 2007; 41:245-252.
25. Mariappan R, Narayana Prabhu AH, Kuppuswamy B. Comparing the Effects of Oral Clonidine Premedication With Intraoperative Dexmedetomidine Infusion on Anesthetic Requirement and Recovery From Anesthesia in Patients Undergoing Major Spine Surgery. J Neurosurg Anesthesiol 2014; 26:192-197.
26. Shin HW, Yoo HN, Kim DH, Lee H, Shin HJ, Lee HW. Preanesthetic dexmedetomidine 1 microg/kg single infusion is a simple, easy, and economic adjuvant for general anesthesia. Korean J Anesthesiol 2013; 65:114-120.
27. Unlugenc H, Gunduz M, Guler T, Yagmur O, Isik G. The effect of preanaesthetic administration of intravenous dexmedetomidine on postoperative pain in patients receiving patient-controlled morphine. Eur J Anaesthesiol 2005; 22:386-391.
28. Gurbet A, Basagan-Mogol E, Turker G, Ugun F, Kaya FN, Ozcan B. Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements. Can J Anaesth 2006; 53:646-652.
29. Ohtani N, Yasui Y, Watanabe D, Kitamura M, Shoji K, Masaki E. Perioperative infusion of dexmedetomidine at a high dose reduces postoperative analgesic requirements: a randomized control trial. J Anesth 2011; 25:872-878.
30. Blaudszun G, Lysakowski C, Elia N, Tramer MR. Effect of perioperative systemic alpha2 agonists on postoperative morphine consumption and pain intensity: systematic review and meta-analysis of randomized controlled trials. Anesthesiology 2012; 116:1312-1322.